Targeting multiple myeloma cells

Targeting multiple myeloma cells (MM.1S) involves using aptamers—short, single-stranded DNA molecules—that bind specifically to surface markers on malignant plasma cells. MM.1S is a well-established cell line derived from a multiple myeloma patient and is widely used in drug development and disease modeling.

Latest Post

Scroll to Top